"India is a key partner for us, because India will, de facto, produce as much of the vaccine as Russia. It will be one of the main manufacturing centres of Sputnik V vaccine in the world. We expect to submit [paperwork] for registration of the vaccine either this month or the next one, our [Indian] partner Dr. Reddy's is working on it," Dmitriev told a briefing.
"So, after that we will be able to start shipments to India. We could even say that Sputnik V is a Russian-Indian vaccine because we have five partners for manufacturing there," Dmitriev said.
